Skip to content

An observational study to evaluate how to early diagnosis and treatment the patients with eosinophilic granulomatosis with polyangiitis

how to early diagnosis and treatment the patients with eosinophilic granulomatosis with polyangiitis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIC-15007622
Enrollment
Unknown
Registered
2015-12-07
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGPA

Interventions

asthma:ICS
EGPA only lung:oral glucocorticoid
EGPA only lung 2:oral glucocorticoid and CTX
EGPA:oral glucocorticoid and CTX

Sponsors

The first affiliated hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) asthma; (2) peripheral blood eosinophilia (eosinophil ratio higher than 10% or the absolute value is more than 1.5*10^9/L); (3) the X-ray manifestations of non fixed pulmonary infiltration.

Exclusion criteria

Exclusion criteria: Combined with other organs of the non vascular disease.

Design outcomes

Primary

MeasureTime frame
the frequency of asthmtic symptom;

Secondary

MeasureTime frame
PEF;the absolute value of eosinophil;

Countries

China

Contacts

Public ContactQingling Zhang
zqling68@hotmail.com+86 13609068871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026